CYLD and bladder transitional cell carcinoma: In addition, although there is no statistical significance, there was a trend that the lower expression level of USP45, the longer OS and RFS of patients with BLCA, EAC, KIRC, PCPG, UCEC, LIHC, BRCA, HNSC, and LUAD (Supplementary Figure S1).